(Q38534570)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26099829%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

review article

1 reference

title

Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26099829%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26099829%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Robert G Britton

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26099829%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Christina Kovoor

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26099829%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

language of work or name

English

0 references

publication date

22 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26099829%20AND%20SRC:MED&resulttype=core&format=json

Annals of the New York Academy of Sciences

17 February 2020

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26099829%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

1348

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26099829%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26099829%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

124-133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26099829%20AND%20SRC:MED&resulttype=core&format=json

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Mechanisms of cardiovascular protection by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Cardiovascular effects and molecular targets of resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Resveratrol: a multitargeted agent for age-associated chronic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Resveratrol role in cardiovascular and metabolic health and potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Fruits and dietary phytochemicals in bone protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Observation of human retinal remodeling in octogenarians with a resveratrol based nutritional supplement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Sirtuin activators mimic caloric restriction and delay ageing in metazoans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Resveratrol, sirtuins, and the promise of a DR mimetic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Resveratrol as a therapeutic agent for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Finding a target for resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Resveratrol: anti-obesity mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

mTOR: more targets of resveratrol?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Regulation of microRNAs by natural agents: new strategies in cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Control of MicroRNA expression as a new way for resveratrol to deliver its beneficial effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Inactivation of creatine kinase induced by stilbene derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Resveratrol directly targets COX-2 to inhibit carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

COX-2 as a target for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Pleiotropic mechanisms facilitated by resveratrol and its metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A₄hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Targeting cellular metabolism to improve cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Fatty acid synthase as a potential therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Fatty acid synthase and cancer: new application of an old pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Structure-activity relationship of polyphenols that inhibit fatty acid synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Identification of carbonyl reductase 1 as a resveratrol-binding protein by affinity chromatography using 4'-amino-3,5-dihydroxy-trans-stilbene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Crystal structure of quinone reductase 2 in complex with resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Association of NRH:quinone oxidoreductase 2 gene promoter polymorphism with higher gene expression and increased susceptibility to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Combining computational and biochemical studies for a rationale on the anti-aromatase activity of natural polyphenols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Peroxisome proliferator-activated receptor gamma and lung cancer biology: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Resveratrol and Its Metabolites Bind to PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer's disease: a translational overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Phosphodiesterase inhibition in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Roflumilast : the new orally active, selective phophodiesterase-4 inhibitor, for the treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Catalytic inhibition of human DNA topoisomerase II by interactions of grape cell culture polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Molecular mechanism of the chemopreventive effect of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

AKT/PKB signaling: navigating downstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Biochemical and cellular evidence demonstrating AKT-1 as a binding partner for resveratrol targeting protein NQO2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

AKT crystal structure and AKT-specific inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Cell cycle kinases as therapeutic targets for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

DNA polymerases and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Inhibition of protein kinase C by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Effects of resveratrol on the autophosphorylation of phorbol ester-responsive protein kinases: inhibition of protein kinase D but not protein kinase C isozyme autophosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Protein kinase C, an elusive therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Emerging roles of protein kinase D1 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Inhibition of protein kinase D by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Chemistry: Chemical con artists foil drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Histone deacetylase inhibitors: overview and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Are sirtuins viable targets for improving healthspan and lifespan?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Resveratrol is not a direct activator of SIRT1 enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Mechanism of human SIRT1 activation by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Inhibitory effects of grape skin extract and resveratrol on fatty acid synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Interaction of resveratrol and genistein with nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Interaction of transresveratrol with plasma lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12796

21 January 2018

Identifiers

DOI

10.1111/NYAS.12796

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26099829%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference